In Post-delivery bleeding Wergomet 0.125mg Tablet helps to control excessive bleeding after giving birth. This helps to prevent severe loss of blood that can lead to dropping of blood pressure, shock and even death if not controlled in time. It helps proper contraction of the uterus and therefore prevents hemorrhage and further complications.
It is not known whether it is safe to consume alcohol with Wergomet 0.125mg Tablet. Please consult your doctor.
Wergomet 0.125mg Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Wergomet 0.125mg Tablet should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
It is not known whether Wergomet 0.125mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
There is limited information available on the use of Wergomet 0.125mg Tablet in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Wergomet 0.125mg Tablet in patients with liver disease. Please consult your doctor.
If you miss a dose of Wergomet 0.125mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Intas Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Galpha Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Shalman Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: PPL Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lupin Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Pax Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Oyster Labs Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Remedial Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: BPL || ₹14.5/tablet (25% cheaper)